The OpenAI Foundation has announced plans to distribute over $100 million in grants aimed at advancing AI-driven research in Alzheimer's disease. This initiative will focus on enhancing drug design and improving early detection methods for the disease. The substantial funding underscores the foundation's commitment to leveraging artificial intelligence in tackling complex medical challenges.